These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27568485)

  • 1. Development of an Extended-Release Formulation for Apremilast and a Level A in Vitro-in Vivo Correlation Study in Beagle Dogs.
    Tang M; Hu P; Huang S; Zheng Q; Yu H; He Y
    Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1607-1615. PubMed ID: 27568485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
    Le TC; Mateescu MA
    Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
    Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
    Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs.
    Wu B; Deng D; Lu Y; Wu W
    Eur J Pharm Biopharm; 2008 May; 69(1):294-302. PubMed ID: 17988844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical Product Lead Optimization for Better In vivo Bioequivalence Performance: A case study of Diclofenac Sodium Extended Release Matrix Tablets.
    Shahiwala A; Zarar A
    Curr Drug Deliv; 2018; 15(5):705-715. PubMed ID: 29165078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.
    Medeiros DC; Mazon-Cardoso T; Lemos-Senna E; Poli A
    Pharmazie; 2009 Oct; 64(10):648-52. PubMed ID: 19947166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel extended in vitro-in vivo correlation model for the development of extended-release formulations for baclofen: From formulation composition to in vivo pharmacokinetics.
    Kim TH; Bulitta JB; Kim DH; Shin S; Shin BS
    Int J Pharm; 2019 Feb; 556():276-286. PubMed ID: 30543888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
    Lim JY; Kim TH; Song CH; Kim DH; Shin BS; Shin S
    J Control Release; 2022 Mar; 343():443-456. PubMed ID: 35124130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A time-adjustable pulsatile release system for ketoprofen: In vitro and in vivo investigation in a pharmacokinetic study and an IVIVC evaluation.
    Wang H; Cheng L; Wen H; Li C; Li Y; Zhang X; Wang Y; Wang Y; Wang T; Pan W; Yang X
    Eur J Pharm Biopharm; 2017 Oct; 119():192-200. PubMed ID: 28633956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
    Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
    J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.
    Yaro P; He X; Liu W; Xun M; Ma Y; Li Z; Shi X
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1670-6. PubMed ID: 24102615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
    Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
    Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability.
    Lin Q; Fu Y; Li J; Qu M; Deng L; Gong T; Zhang Z
    Eur J Pharm Sci; 2015 Nov; 79():44-52. PubMed ID: 26349052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.
    Ochoa L; Igartua M; Hernández RM; Solinís MA; Gascón AR; Pedraz JL
    Eur J Pharm Biopharm; 2010 Jun; 75(2):232-7. PubMed ID: 20159037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.